Navigation Links
NIST and partners identify tiny gold clusters as top-notch catalysts
Date:9/5/2008

For most of us, gold is only valuable if we possess it in large-sized pieces. However, the "bigger is better" rule isn't the case for those interested in exploiting gold's exceptional ability to catalyze a wide variety of chemical reactions, including the oxidation of poisonous carbon monoxide (CO) into harmless carbon dioxide at room temperatures. That process, if industrialized, could potentially improve the effectiveness of catalytic converters that clean automobile exhaust and breathing devices that protect miners and firefighters. For this purpose, nanoclustersgold atoms bound together in crystals smaller than a strand of DNAare the size most treasured.

Using a pair of scanning transmission electron microscopy (STEM) instruments for which spherical aberration (a system fault yielding blurry images) is corrected, researchers at the National Institute of Standards and Technology (NIST), Lehigh University (Bethlehem, Pa.) and Cardiff University (Cardiff, Wales, United Kingdom) for the first time achieved state-of-the-art resolution of the active gold nanocrystals absorbed onto iron oxide surfaces. In fact, the resolution was sensitive enough to even visualize individual gold atoms.

The work is reported in the Sept. 5, 2008, issue of Science.

Surface science studies have suggested that there is a critical size range at which gold nanocrystals supported by iron oxide become highly active as catalysts for CO oxidation. However, the theory is based on research using idealized catalyst models made of gold absorbed on titanium oxide. The NIST/Lehigh/Cardiff aberration-corrected STEM imaging technique allows the researchers to study the real iron oxide catalyst systems as synthesized, identify all of the gold structures present in each sample, and then characterize which cluster sizes are most active in CO conversion.

The research team discovered that size matters a lotsamples ranged from those with little or no catalytic activity (less than 1 percent CO conversion) to others with nearly 100 percent efficiency. Their results revealed that the most active gold nanoclusters for CO conversion are bilayers approximately 0.5-0.8 nanometer in diameter (40 times smaller than the common cold virus) and containing about 10 gold atoms. This finding is consistent with the previous surface science studies done on the gold-titanium oxide models.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology technology :

1. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
2. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
3. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
4. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
5. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
10. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
11. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIST and partners identify tiny gold clusters as top-notch catalysts
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):